Update on Recurrent Respiratory Papillomatosis.

Otolaryngol Clin North Am

Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Sentara Norfolk General Hospital, 600 Gresham Drive, Suite 1100, Norfolk, VA 23507, USA.

Published: August 2019

Recurrent respiratory papillomatosis (RRP) remains a challenging disease afflicting children and adults, resulting in an estimated $120 million per year in United States healthcare-related costs, with annual costs per patient approaching $60,000. Although the prevalence of RRP has declined, RRP remains the most common benign laryngeal neoplasm in children. RRP is unique in its high rate of multisite recurrence, its high burden on patient quality of life, and its high associated healthcare costs. This article summarizes current understanding of the natural history and quality of life burden of RRP, and basic science advancements in prevention and treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.otc.2019.03.011DOI Listing

Publication Analysis

Top Keywords

recurrent respiratory
8
respiratory papillomatosis
8
rrp remains
8
quality life
8
rrp
5
update recurrent
4
papillomatosis recurrent
4
papillomatosis rrp
4
remains challenging
4
challenging disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!